The Elevated Risk of Dementia in Parkinson's Disease Patients Associated with Metabolic Syndrome

Background: Metabolic syndrome (MetS) is prevalent in the general population, and recent findings have highlighted its role as an independent risk factor for cognitive impairment. The primary objective of this study is to explore the association between MetS and the risk of cognitive impairment within the Parkinson's disease (PD) population.
Source: Parkinsonism and Related Disorders - Category: Neurology Authors: Source Type: research